Business · 27/01/2020
FDA Extends Comment Period for Draft Guidance on Human Drug and Biological Products
The Food and Drug Administration (FDA) is extending the comment period for a draft guidance on demonstrating substantial evidence of effectiveness for human drugs and biological products. The extension is in response to requests from interested persons to provide additional time to submit comments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →